Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMS effects on retinal microvasculature in TRD
NCT06708013Completed
- Sponsor
- Gulhane Training and Research Hospital
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Gulhane Training and Research Hospital. Primary endpoint: Changes in Retinal and Choroidal Microvasculature at 4 weeks. Started Jan 2023; status: completed.
Beyond the preview
Go deeper on NCT06708013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708013.